Bob D Brown insider trades: Dicerna Pharmaceuticals (DRNA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Bob reports to the SEC
Open-market buys and sales
28 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 18, 2021 | DRNA | ↓ Sell | 24,936 | $37.94 | $946K | Direct | Nov 22, 2021 (4d) |
| Sep 17, 2021 | DRNA | ↓ Sell | 21,250 | $21.06 | $448K | Direct | Sep 21, 2021 (4d) |
| Aug 2, 2021 | DRNA | ↓ Sell | 8,312 | $37.38 | $311K | Direct | Aug 3, 2021 (1d) |
| Jul 1, 2021 | DRNA | ↓ Sell | 8,312 | $37.37 | $311K | Direct | Jul 6, 2021 (5d) |
| Jun 11, 2021 | DRNA | ↓ Sell | 10,000 | $34.00 | $340K | Direct | Jun 15, 2021 (4d) |
| Jun 7, 2021 | DRNA | ↓ Sell | 10,000 | $33.00 | $330K | Direct | Jun 8, 2021 (1d) |
| Jun 1, 2021 | DRNA | ↓ Sell | 8,312 | $30.93 | $257K | Direct | Jun 3, 2021 (2d) |
| May 3, 2021 | DRNA | ↓ Sell | 8,312 | $30.28 | $252K | Direct | May 5, 2021 (2d) |
| Apr 30, 2021 | DRNA | ↓ Sell | 20,000 | $31.50 | $630K | Direct | May 3, 2021 (3d) |
| Apr 1, 2021 | DRNA | ↓ Sell | 8,312 | $25.87 | $215K | Direct | Apr 5, 2021 (4d) |
| Mar 1, 2021 | DRNA | ↓ Sell | 8,312 | $28.96 | $241K | Direct | Mar 2, 2021 (1d) |
| Feb 3, 2021 | DRNA | ↓ Sell | 8,312 | $25.00 | $208K | Direct | Feb 4, 2021 (1d) |
| Jan 25, 2021 | DRNA | ↓ Sell | 21,630 | $25.00 | $541K | Direct | Jan 27, 2021 (2d) |
| Jan 12, 2021 | DRNA | ↓ Sell | 5,808 | $24.07 | $140K | Direct | Jan 13, 2021 (1d) |
| Dec 1, 2020 | DRNA | ↓ Sell | 8,185 | $25.19 | $206K | Direct | Dec 3, 2020 (2d) |
| Nov 2, 2020 | DRNA | ↓ Sell | 8,185 | $21.03 | $172K | Direct | Nov 3, 2020 (1d) |
| Oct 16, 2020 | DRNA | ↓ Sell | 16,370 | $21.00 | $344K | Direct | Oct 20, 2020 (4d) |
| Aug 3, 2020 | DRNA | ↓ Sell | 8,185 | $22.48 | $184K | Direct | Aug 5, 2020 (2d) |
| Jul 1, 2020 | DRNA | ↓ Sell | 8,185 | $26.50 | $217K | Direct | Jul 6, 2020 (5d) |
| Jun 19, 2020 | DRNA | ↓ Sell | 9,670 | $25.00 | $242K | Direct | Jun 23, 2020 (4d) |
| Jun 1, 2020 | DRNA | ↓ Sell | 8,185 | $21.01 | $172K | Direct | Jun 2, 2020 (1d) |
| May 11, 2020 | DRNA | ↓ Sell | 13,281 | $24.00 | $319K | Direct | May 12, 2020 (1d) |
| May 5, 2020 | DRNA | ↓ Sell | 8,185 | $21.00 | $172K | Direct | May 7, 2020 (2d) |
| Apr 20, 2020 | DRNA | ↓ Sell | 21,466 | $22.31 | $479K | Direct | Apr 21, 2020 (1d) |
| Mar 2, 2020 | DRNA | ↓ Sell | 8,185 | $21.00 | $172K | Direct | Mar 3, 2020 (1d) |
| Feb 10, 2020 | DRNA | ↓ Sell | 8,185 | $21.00 | $172K | Direct | Feb 11, 2020 (1d) |
| Dec 31, 2019 | DRNA | ↓ Sell | 34,747 | $21.90 | $761K | Direct | Dec 31, 2019 (0d) |
| May 9, 2018 | DRNA | ↓ Sell | 9,669 | $15.00 | $145K | Direct | May 11, 2018 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Bob D Brown's insider trades
Bob D Brown is Chief Scientific Ofr., EVP R&D at Dicerna Pharmaceuticals (DRNA). Since May 9, 2018, Bob has reported no open-market purchases and 28 sales worth $8.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (29 filings), grants and awards (8 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DRNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.